Skip to main content
Caplight Logo









Evogenom Oy

Evogenom Oy

Private
JyväskyläHealthcare & Life Scienceshttps://evogenom.com/

Last Round

Early Funding

Oct 8, 2024

Company Overview

Evogenom Oy is a biotechnology company that provides direct-to-consumer genetic testing services and personalized wellness recommendations through its mobile application and AI-powered coaching platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Sports & Fitness

Business Model

B2C

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Keywords

genetic testingDNA testpersonalized wellnessbiohackingAI wellness coachat-home DNA kitnutrigenomicsprecision medicinefitness optimizationdirect-to-consumerD2Chabit trackinghealth techbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evogenom Oy Comparables

Compare Evogenom Oy with similar companies based on industry and business-model similarity.

Evogenom Oy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FitnessGenes
82%
Muhdo Health
81%
GenoPalate, Inc.
81%

Evogenom Oy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 8, 2024

Key People

Founding team and executive leadership

Sofia Lund

Founder, CEO

Founding Team

Evogenom Oy Investors

Notable investors and investment history

Evogenom Oy investors
InvestorRounds
Trind VCEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Monthly visitors increased 135% MoM, reaching 4.4K.

  • Oct 8, 2024

    Trind VC led the early funding round.

Evogenom Oy Filings

Explore SEC and related filing metadata, where available.

Evogenom Oy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Evogenom Oy's valuation, stock price, and market status.

Is Evogenom Oy a public or private company?

Evogenom Oy is a private company.

What is the current stock price of Evogenom Oy?

Evogenom Oy is a private company with no public stock price. No recent secondary market data is available.

How much is Evogenom Oy worth (valuation)?

Valuation information for Evogenom Oy is not publicly available.

Can I buy Evogenom Oy stock?

Evogenom Oy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Evogenom Oy's last funding round?

Evogenom Oy's most recent funding round was Early Funding on October 8, 2024.

Who are the main investors in Evogenom Oy?

Key investors in Evogenom Oy include Trind VC.

Will Evogenom Oy IPO soon?

No public IPO plans have been announced for Evogenom Oy.

How can I track Evogenom Oy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evogenom Oy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJyväskylä
Employee Range11
Year Founded2016
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?